Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy

BACKGROUND: Synthetic adrenocorticotropic hormone (ACTH) has been demonstrated to be effective in patients with membranous nephropathy, minimal change disease and some histological subtypes of focal segmental glomerulosclerosis. Its clinical impact in patients with IgA nephropathy is currently uncle...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Bhanu, Giebel, Shelley, McCarron, Michelle C. E., Leung, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966849/
https://www.ncbi.nlm.nih.gov/pubmed/29792169
http://dx.doi.org/10.1186/s12882-018-0915-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966849/
https://www.ncbi.nlm.nih.gov/pubmed/29792169
http://dx.doi.org/10.1186/s12882-018-0915-4

Ejemplares similares